FINWIRES · TerminalLIVE
FINWIRES

Yamaichi Electronics to Transfer 15% Stake in Unit to VS Technology

By

Yamaichi Electronics (TYO:6941) has resolved to transfer 32,400 shares, or 15% of voting rights, in wholly owned subsidiary Koshin Kogaku (KKC) to VS Technology.

The share transfer agreement was executed on Sept. 18, and closing is scheduled for Sept. 25, according to a Tokyo bourse filing.

The transfer aims to strengthen the group's optical-related business by combining KKC's manufacturing capabilities with VS Tech's established overseas sales network to expand sales.

KKC and VST already have a business relationship, with KKC's products used in filters of VST's

machine vision lenses, the filing said.

Yamaichi Electronics will retain 85% ownership of KKC, which will remain a consolidated subsidiary.

What else is happening in Asia?

Asia

Newlink Technology's Potential Acquisition of HK Ant Global Investment Falls Through

Newlink Technology (HKG:9600) terminated a memorandum of intent for the potential acquisition of HK Ant Global Investment.The parties had entered the memorandum in May, a Friday bourse filing showed.

HKG:9600
Asia

New Concepts Raises HK$4.9 Million from Share Issue

New Concepts Holdings (HKG:2221) completed the issue of 5 million new shares to Du Lei to raise net proceeds of nearly HK$4.9 million.The parties had entered into the share subscription agreement earlier in September, a Friday bourse filing showed.The construction company plans to use proceeds for general working capital.

HKG:2221
Asia

Eternity Investment Unit, Director Dispose Of Stake in China Healthwise

Eternity Investment (HKG:0764) unit Eternity Finance and executive director Lei Hong Wai agreed to sell around 169 million and 18.7 million respective shares in China Healthwise (HKG:0348).The shares, representing an 18.3% and 2% stake in China Healthwise, respectively, were sold to Hwa Sheng International Investment at HK$0.08 apiece, a Friday bourse filing showed.The company will receive a consideration of around HK$13.5 million from the disposal and cease to hold any stake in China Healthwise following completion.Proceeds will be used to repay a margin loan, as well as for general working capital.

HKG:0348HKG:0764